Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net loss $ (1,429,179) $ (503,776)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 16,712 10,836
Reduction in the carrying amount of right-of-use assets 20,970 19,063
Stock-based compensation 112,330 118,405
Goodwill impairment 1,000,081 0
Change in fair value of derivative liabilities (103,057) 0
Non-cash severance 0 7,873
Change in deferred tax asset valuation allowance 0 (2,638)
Other 909 6,714
Changes in operating assets and liabilities:    
Contract asset 32,538 (5,599)
Prepaid expenses and other current assets 20,325 (3,979)
Other assets (2,131) (1,071)
Accounts payable (9,115) (4,657)
Operating lease liabilities (19,085) (16,785)
Accrued expenses and other current and non-current liabilities (9,131) (45,240)
Net cash used in operating activities (367,833) (420,854)
Cash flows from investing activities    
Purchases of property and equipment (11,841) (32,128)
Net cash acquired in acquisitions 0 294,439
Purchase of short-term investments (1,219,841) 0
Maturities of short-term investments 466,000 0
Other (110) 0
Net cash (used in) provided by investing activities (765,792) 262,311
Cash flows from financing activities    
Proceeds from issuance of common stock 12,117 4,709
Proceeds from issuance of Series U-2 preferred stock, net 0 397,862
Other (1,725) 0
Net cash provided by financing activities 10,392 402,571
Net (decrease) increase in cash, cash equivalents, and restricted cash (1,123,233) 244,028
Cash, cash equivalents, and restricted cash at beginning of the period 1,626,247 399,828
Cash, cash equivalents, and restricted cash at end of the period $ 503,014 $ 643,856